Table 1.
Summary of cardiovascular risk factors (presented as either prevalence; mean ± standard deviation; or median [first quartile, third quartile]) in relation to categories defined according to chronological age at study baseline. HDL = high-density lipoprotein; PCE = Pooled Cohort Equations Risk Model; ASCVD = atherosclerotic cardiovascular disease.
| Age at Study Baseline | |||
|---|---|---|---|
| Variable | 65–74 Years | 75–84 Years | 85+ Years |
| (N = 15,290) | (N = 8,082) | (N = 1,977) | |
| Sex (% male) | 45 | 40 | 34 |
| Age (years) | 69 [66, 71] | 79 [76, 81] | 87 [86, 89] |
| African American Race (%) | 14 | 14 | 12 |
| Total Cholesterol (mg/dL) | 175 ± 46 | 168 ± 46 | 164 ± 45 |
| HDL Cholesterol (mg/dL) | 57 ± 17 | 58 ± 17 | 58 ± 17 |
| Antihypertensive Use (%) | 69 | 80 | 86 |
| Statin Use (%) | 53 | 55 | 52 |
| Type II Diabetes Mellitus (%) | 22 | 23 | 18 |
| Smoking (%) | 11 | 6 | 3 |
| Systolic Blood Pressure (mmHg) | 130 ± 14 | 132 ± 15 | 133 ± 16 |
| Diastolic Blood Pressure (mmHg) | 76 ± 9 | 73 ± 9 | 70 ± 9 |
| PCE-Estimated 5-Year ASCVD Event Risk (%) | 5.3 [3.2, 8.3] | 12.6 [8.9, 17.7] | 26.4 [19.8, 35.2] |
| - Among African American Males | 8.9 [6.2, 12.3] | 10.7 [7.8, 15.2] | 13.7 [10.4, 17.1] |
| - Among Caucasian Males | 7.8 [5.6, 10.7] | 15.7 [11.9, 20.5] | 25.8 [21.3, 32.9] |
| - Among African American Females | 5.6 [3.7, 8.2] | 8.8 [6.0, 13.3] | 13.3 [9.3, 18.7] |
| - Among Caucasian Females |
3.3 [2.2, 4.9] | 11.2 [8.0, 15.9] | 29.4 [22.3, 39.1] |